Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Contact Us
If you have any questions or feedback please contact us.

Esteban M Lucero

TitlePost-Doctoral Fellow
InstitutionUniversity of Colorado Denver - Anschutz Medical Campus
DepartmentSOM-BIOMED Informatics Gen Ops

    Collapse Research 
    Collapse research activities and funding
    K00AG080847     (LUCERO, ESTEBAN M)Sep 1, 2019 - Jun 30, 2026
    NIH
    Understanding the role of genetic admixture on Alzheimer?s Disease risk in Lat?no Populations
    Role: Principal Investigator

    F99NS115330     (LUCERO, ESTEBAN M)Sep 1, 2019 - Aug 31, 2021
    NIH
    Targeting Kinesin-5 Activity for treatment of Alzheimer's disease
    Role: Principal Investigator

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    List All   |   Timeline
    1. Dooling BR, Vielle A, Lucero EM, Rydland C, Quang D, Summers R, Esquer H, Coughlan C, Galbraith MD, Espinosa JM, LaBarbera DV, Chial HJ, Potter H, Ledreux A, Johnson NR. Trisomy 21 cerebral organoids exhibit Alzheimer's disease amyloid and apolipoprotein E co-pathologies. bioRxiv. 2026 Jul 07. PMID: 42465338.
      View in: PubMed
    2. Boeriu AI, Gu T, Fullton-Howard B, Lucero EM, Shortt J, Gignoux C, Rajabli F, Griswold AJ, Yaffe K, Andrews SJ. Ancestry-specific effects of APOE on Alzheimer Disease Endophenotypes. medRxiv. 2026 Mar 25. PMID: 41929284.
      View in: PubMed
    3. Lucero EM, Freund RK, Smith A, Johnson NR, Dooling B, Sullivan E, Prikhodko O, Ahmed MM, Bennett DA, Hohman TJ, Dell'Acqua ML, Chial HJ, Potter H. Increased KIF11/kinesin-5 expression offsets Alzheimer Aß-mediated toxicity and cognitive dysfunction. iScience. 2022 Nov 18; 25(11):105288. PMID: 36304124.
      View in: PubMed
    4. Johnson NR, Wang AC, Coughlan C, Sillau S, Lucero E, Viltz L, Markham N, Allen C, Dhanasekaran AR, Chial HJ, Potter H. Imipramine and olanzapine block apoE4-catalyzed polymerization of Aß and show evidence of improving Alzheimer's disease cognition. Alzheimers Res Ther. 2022 06 29; 14(1):88. PMID: 35768831.
      View in: PubMed
    Lucero's Networks
    Click the "See All" links for more information and interactive visualizations!
    Concepts Expand Description
    _
    Co-Authors Expand Description
    _
    Similar People Expand Description
    _
    Same Department Expand Description

    Copyright © 2026 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)